| 000 | 01907 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517124710.0 | ||
| 264 | 0 | _c20170529 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1090-2104 | ||
| 024 | 7 |
_a10.1016/j.bbrc.2016.11.083 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAitken, Jacqueline F | |
| 245 | 0 | 0 |
_aRutin suppresses human-amylin/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin/hIAPP transgenic mice. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cJan 2017 |
||
| 300 |
_a625-631 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmyloid _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aIslet Amyloid Polypeptide _xgenetics |
| 650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aProtein Aggregation, Pathological _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Folding _xdrug effects |
| 650 | 0 | 4 |
_aProteostasis Deficiencies _xdrug therapy |
| 650 | 0 | 4 |
_aRutin _xpharmacology |
| 700 | 1 | _aLoomes, Kerry M | |
| 700 | 1 | _aRiba-Garcia, Isabel | |
| 700 | 1 | _aUnwin, Richard D | |
| 700 | 1 | _aPrijic, Gordana | |
| 700 | 1 | _aPhillips, Ashley S | |
| 700 | 1 | _aPhillips, Anthony R J | |
| 700 | 1 | _aWu, Donghai | |
| 700 | 1 | _aPoppitt, Sally D | |
| 700 | 1 | _aDing, Ke | |
| 700 | 1 | _aBarran, Perdita E | |
| 700 | 1 | _aDowsey, Andrew W | |
| 700 | 1 | _aCooper, Garth J S | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 482 _gno. 4 _gp. 625-631 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2016.11.083 _zAvailable from publisher's website |
| 999 |
_c26621386 _d26621386 |
||